ARCHIVES

One Flexible Sigmoidoscopy Can Reduce Risk by 31 Percent

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

Biostatistician Thomas Fleming Warns Against Approval of Provenge.

May 4, 2007

Bristol Stock Drops Amid New Setbacks, Deepening Firm’s Decline In Oncology

April 5, 2002

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003

Pharmacia Corp. Forms $1 Million Fund To Support Anthracycline Research.

June 2, 2000

Federal AIDS Funds Tp $2 Bil.; Term Proposed For NIH Director

October 19, 1990

December issue of Business & Regulatory Report included (an additional 8 pages of industry news).

December 10, 2004